-
Wsparcie przedrejestracyjne
- Regulatory roadmap
- Usługa Scientific Advice
-
Dokumentacja rejestracyjna
- Audyt dossier
Proces rejestracji
Obsługa porejestracyjna
MENU
Blog
Medicinal products advertisement – what is it and what requirements must it fulfill?
02 sierpnia 2023
Nowadays it is difficult to imagine an economic entity functioning without using any form of advertisement. What about medicinal products? Do life-saving and life-enhancing products also need advertising? Do medicines which have pervaded our daily lives need to be additionally advertised? On the other hand, how do we know whether to choose company A’s medicine or company B’s medicine for a headache? The rules for advertising medicinal products are laid […]
Is market analysis important for pharmaceutical project success?
20 lipca 2023
Big pharma has the unlimited budgets, but is it true? In 2012 the medical and patient world held its breath because of Sanofi’s new product launch – Zaltrap (afibercept), a medicinal product registered for the treatment of colon cancer and its price of 9600 $/month. The price of Avastin (bevacizumab), its closest competitor, was half of its price, since Sanofi’s treatment was so expensive, oncologists […]
How to increase the safety of used cosmetics? A few words about cosmetovigilance
12 lipca 2023
Every day, a lot of people experience side effects after using cosmetics, but not everyone knows that they can report them to the responsible authorities. Why reporting adverse reactions is important and how it affects the safety of cosmetics? If you want to find out what cosmetovigilance is – we invite you to read the article. Pharmacovigilance vs cosmetovigilance – what is the difference? The term „pharmacovigilance” […]